Despite many advancements in lung cancer therapies, this disease remains the leading cause of cancer-related deaths in the United States and around the world. Ohio University researchers have discovered a new way…
Category: Lung Cancer Treatment
Get to know about types of lung cancer treatment methods, causes, researches, early symptoms and stages. To know more details about the lung cancers browse the website.
Inhalable Gene Therapy for Advanced Lung Cancer
Lung Cancer is the deadliest form of disease and one of the reasons that lung cancer is becoming difficult to treat is that the treatments administered orally or intravenously have difficulty in…
Markey Cancer Center Treats First US Patient with Alveltamig for Small Cell Lung Cancer
The University of Kentucky Markey Cancer Center has treated the first patient in US with a new immunotherapy for lung cancer. UK Markey Cancer Center becomes the first site in the country…
Why International Patients Choose India for Lung Cancer Treatment
Lung cancer is a global health challenge and millions of people are getting trapped in the vicious circle of this disease. People from different regions of the world seeking quality and timely…
Role of Personalized Treatment for Lung Cancer Patients
Lung cancer is one of the most deadly disease and is responsible for many deaths each year. There are two major types of lung cancer: small cell and non-small cell lung cancer….
Lurbinectedin Combination gets FDA Approval for Extensive-Stage SCLC
The U.S. Food and Drug Administration (FDA) has approved lurbinectedin (Zepzelca) in combination with atezolizumab or and hyaluronidase-tqjs for adults with extensive-stage small cell lung cancer (ES-SCLC) without disease progression after frontline…
FDA Grants Breakthrough Therapy to Olomorasib to Treat Lung Cancer
Eli Lilly and Company has announced that US Food and Drug Administration (FDA) has granted breakthrough therapy designation to olomorasib, in combination with anti-PD1 therapy Keytruda for first-line treatment of patients with…
FDA Approves Hernexeos for HER2-Mutant Advanced Lung Cancer
For the first time, FDA has given approval of an oral treatment of patients with unresectable or metastatic non-squamous non-small cell lung cancer whose tumors have human epidermal growth factor receptor 2…